Dr Lalchandani Labs Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.96 as of 23 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 55.9 on March 2021 to 2533 on March 2026 . This represents a CAGR of 88.83% over 6 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 6.02 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 87.14 crore on March 2021 to ₹ 210.77 crore on March 2026 . This represents a CAGR of 15.86% over 6 years The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 17.27 crore as compare to the Mar '26 revenue of ₹ 14.09 crore. This represent the growth of 22.57% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 0.95 crore. This represent the growth of 231.58% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0.62 crore to ₹ 0.61 crore over 9 quarters. This represents a CAGR of -0.72% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Lotus Eye Hospital & Institute Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Lotus Eye Hospital & Institute Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Lotus Eye Hospital & Institute Ltd is 234 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Lotus Eye Hospital & Institute Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Lotus Eye Hospital & Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Lotus Eye Hospital & Institute Ltd?

As of October 25, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.96. On the other hand, Lotus Eye Hospital & Institute Ltd stock price is INR ₹112.75.

How do dividend payouts of Dr Lalchandani Labs Ltd and Lotus Eye Hospital & Institute Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Lotus Eye Hospital & Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.